Company
United StatesMitsubishi Tanabe Pharma Development America, Inc., Jersey City, NJ – FDA Inspections
Inspection records and compliance data for Mitsubishi Tanabe Pharma Development America, Inc. in Jersey City, New Jersey. 3 FDA inspections on record, last inspected September 18, 2025.
Company Profile
This profile covers Mitsubishi Tanabe Pharma Development America, Inc. based in Jersey City, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected December 4, 2013. Last inspected September 18, 2025.
Most cited issue areas
- Failure to develop written procedures1 inspection
- General responsibilities of sponsors1 inspection
- Late submission of quarterly safety reports1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 18, 2025 | Not classified | Human Drugs | 1298296 |
| October 15, 2021 | VAI | Human Drugs · Bioresearch Monitoring | 1155136 |
| December 4, 2013 | VAI | Human Drugs · Bioresearch Monitoring | 857641 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Mitsubishi Tanabe Pharma Development America, Inc.
FEI Number
3003777563
Address
525 Washington Blvd Ste 400, Jersey City, New Jersey 07310, United States
Country
United States
ID: f5e77e46-b625-4cdd-a44a-ecd7583b6baa